Nov 11th, 2021
Clinical Interest Article
iFR-SWEDEHEART—Coverage of TCT 2021
Five-year outcomes of a randomized trial of iFR-guided vs. FFR-guided PCI.
Nov 11th, 2021
Clinical Interest Article
MASTER-DAPT—Coverage of TCT 2021
A randomized trial of abbreviated antiplatelet therapy outcomes in high bleeding risk patients with high thrombotic and ischemic risk.
Aug 5th, 2021
Clinical Interest Article
Hospital-Level Percutaneous Coronary Intervention Performance with Simulated Risk-Avoidance Strategies—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
While some hospitals might be tempted to improve their performance rankings by refusing to treat the highest-risk patients, this strategy “is irrati...
Aug 5th, 2021
Clinical Interest Article
Comparison of the ISCHEMIA Trial Population to Patients Undergoing PCI in US Practice: A CathPCI National Cardiovascular Data Registry (NCDR) Research to Practice (R2P) Initiative—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
The population represented in the ISCHEMIA trial for stable ischemic heart disease (SIHD) – which commonly informs contemporary decision-making – do...
Jul 30th, 2021
Clinical Interest Article
SCAI Shock Classification for Mortality Risk Stratification: Survey of Published Evidence—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
SCAI’s recent cardiogenic shock classification system has been confirmed as effective in mortality risk stratification in a new study of more than 1...
Jul 6th, 2021
Clinical Interest Article
Radial Hemostasis and Early TR Band Deflation is Safer and Faster with a Potassium Ferrate Hemostatic Patch (StatSeal)—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
Results from the randomized controlled StatSeal with TR Band Assessment Trial 2 (STAT2)
The use of a potassium ferrate hemostatic patch in additio...
Jul 5th, 2021
Clinical Interest Article
Establishing the Optimal Duration of DAPT After PCI in High Risk TWILIGHT-Like Patients with ACS—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
Prolonged dual antiplatelet therapy (DAPT) should remain the standard of care for high-risk acute coronary syndrome (ACS) patients after percutaneou...
Jul 2nd, 2021
Clinical Interest Article
Update on the North American COVID-19 Myocardial Infarction (NACMI) Registry—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
Primary percutaneous coronary intervention (PCI) and being younger in age were both protective against death in COVID-19-positive patients with ST-s...
Jul 2nd, 2021
Clinical Interest Article
Safety and Efficacy of the Second-Generation Robotic Assisted Systems for PCI—Coverage of Late-Breaking Science at SCAI 2021 Scientific Sessions
The second-generation CorPath GRX robotic system to assist PCI proved to be safe and effective in the final results of the PRECISION GRX Registry.
...
Jul 2nd, 2021
Clinical Interest Article
North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) Registry: Rationale, Design, and Implications
The multicenter NACMI registry will collect data regarding ST elevation on ECG in COVID-19 patients to determine the etiology and associated clinica...